HEMOPHAGOCYTIC HISTIOCYTOSIS (HH) IN RENAL-TRANSPLANT RECIPIENTS UNDER CYCLOSPORINE THERAPY - REPORT OF THE FIRST 2 CASES

被引:0
|
作者
CALONGE, VM [1 ]
GLOTZ, D [1 ]
BOUSCARY, D [1 ]
DUBOUST, A [1 ]
BRUNEVAL, P [1 ]
DRUET, P [1 ]
DIEBOLD, J [1 ]
NOCHY, D [1 ]
机构
[1] HOP HOTEL DIEU,SERV NEPHROL,PARIS,FRANCE
关键词
HEMOPHAGOCYTIC HISTIOCYTOSIS; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; INFECTION;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hematophagocytic histiocytosis is a clinicopathologic syndrome associating fever, liver dysfunction, blood cytopenia and coagulation abnormalities with hematophagocytosis in bone marrow and lymphoid organs. This syndrome is found in immunocompromized patients and is triggered by infection. We describe herein the first 2 cases of HH in renal transplant recipients treated with ciclosporin. In our 1st case, H.H. was not recognized early and the patient died. In the 2nd case, prompt diagnosis associated to an anti-infectious treatment led to recovery. The clinician must thus be aware of the possibility of such a syndrome in renal transplant patients. Identification and treatment of the underlying infection is mandatory to avoid a fatal outcome.
引用
收藏
页码:88 / 91
页数:4
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS - REPLY
    BURKE, JF
    PIRSCH, JD
    SALOMON, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (26): : 1777 - 1778
  • [32] MANAGEMENT OF THE NEPHROTOXICITY OF CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    PONTICELLI, C
    DEVECCHI, A
    EGIDI, F
    TARANTINO, A
    MONTAGNINO, G
    BERARDINELLI, L
    VEGETO, A
    TRANSPLANTATION PROCEEDINGS, 1985, 17 : 61 - 64
  • [33] PROTEINURIA IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    VATHSALA, A
    VERANI, R
    SCHOENBERG, L
    LEWIS, RM
    VANBUREN, CT
    KERMAN, RH
    KAHAN, BD
    TRANSPLANTATION, 1990, 49 (01) : 35 - 41
  • [34] REVERSIBILITY OF CYCLOSPORINE CHRONIC TOXICITY IN RENAL-TRANSPLANT RECIPIENTS
    MOURAD, G
    HALIMI, JM
    RIBSTEIN, J
    MIMRAN, A
    MION, C
    PRESSE MEDICALE, 1991, 20 (40): : 2028 - 2029
  • [35] VALPROATE FOR EPILEPSY IN RENAL-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE
    HILLEBRAND, G
    CASTRO, LA
    VANSCHEIDT, W
    BEUKELMANN, D
    LAND, W
    SCHMIDT, D
    TRANSPLANTATION, 1987, 43 (06) : 915 - 916
  • [36] MISSING IMPACT OF CYCLOSPORINE ON OSTEOPOROSIS IN RENAL-TRANSPLANT RECIPIENTS
    GROTZ, W
    MUNDINGER, A
    GUGEL, B
    EXNER, V
    REICHELT, A
    SCHOLLMEYER, P
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2652 - 2653
  • [37] LIPID ABNORMALITIES IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE
    VATHSALA, A
    WEINBERG, RB
    SCHOENBERG, L
    GREVEL, J
    DUNN, J
    GOLDSTEIN, RA
    VANBUREN, CT
    LEWIS, RM
    KAHAN, BD
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (04) : 3670 - 3673
  • [38] LYMPHOMA IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    CHU, SH
    LAI, MK
    HUANG, CC
    CHUANG, CK
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 1594 - 1595
  • [39] ERYTHROMYCIN-CYCLOSPORINE INTERACTION IN RENAL-TRANSPLANT RECIPIENTS
    HARNETT, JD
    PARFREY, PS
    PAUL, MD
    GAULT, MH
    TRANSPLANTATION, 1987, 43 (02) : 316 - 318
  • [40] VALPROATE FOR EPILEPSY IN RENAL-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE
    FISCHMAN, MA
    HULL, D
    BARTUS, SA
    SCHWEIZER, RT
    TRANSPLANTATION, 1989, 48 (03) : 542 - 542